MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Deep Brain Stimulation Duration and Changes in Basal Ganglia Excitatory/Inhibitory Balance in Children and Young Adults with Dystonia

T. Larsh, D. Gilbert, S. Vadivelu, S. Wu (Cincinnati, USA)

Meeting: 2023 International Congress

Abstract Number: 1023

Keywords: Deep brain stimulation (DBS), Dystonia: Pathophysiology, Dystonia: Treatment

Category: Pediatric Movement Disorders

Objective: We sought to explore associations between basal ganglia aperiodic signals and time since deep brain stimulation (DBS) implantation in children and young adults with dystonia.

Background: Recent advances in DBS devices allow for the recording of local field potentials (LFP) in the clinical setting. LFPs represent the summation of periodic and aperiodic signals, with most prior reports focusing on periodic signals. The aperiodic signal has been suggested to be related to the balance of excitatory and inhibitory neurons, with increased aperiodic signal associated with increase in inhibitory activity.

Method: During standard clinic visits, we collected LFP data from pediatric and young adults with the Percept PC (Medtronic, USA) neurostimulator. Data was collected using the BrainSense Survey function, with the subject at rest. Time between DBS implantation and clinic visit was noted.  LFP data was analyzed using MATLAB and FieldTrip open-source toolbox. The Irregular-Resampling Auto-Spectral Analysis (IRASA) method was used to separate aperiodic and oscillatory components in the power spectrum of LFPs in log-log space. We then quantified the spectral offset (intercept) and spectral exponent (negative slope magnitude) from the linear regression parameters of the IRASA-decomposed aperiodic spectrum. Linear regression modeling was used to assess effects of time since DBS implantation on aperiodic activity (spectral offset and spectral exponent), considering within-subject effects.

Results: Six pediatric and young adults were included (mean age at implantation: 17.3, range: 7.9-27.7). There was a total of 43 LFP recordings available for analysis (35 GPi, 8 STN). Mean time since DBS implantation was 16.3 months (range: 1.6-70.3). Overall, basal ganglia aperiodic activity decreased with time since DBS implantation (spectral offset: p = 0.02; spectral exponent: p = 0.006). However, this varied within individual subjects and appeared to differ between children and young adults.

Conclusion: We found basal ganglia aperiodic activity tended to decrease with time since DBS implantation, indicating more basal ganglia excitation. This was not universal across subjects and may differ between children and young adults. Factors that may have contributed to this finding include changes in plasticity induced by DBS, dystonia, and neurodevelopmental processes.

To cite this abstract in AMA style:

T. Larsh, D. Gilbert, S. Vadivelu, S. Wu. Deep Brain Stimulation Duration and Changes in Basal Ganglia Excitatory/Inhibitory Balance in Children and Young Adults with Dystonia [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/deep-brain-stimulation-duration-and-changes-in-basal-ganglia-excitatory-inhibitory-balance-in-children-and-young-adults-with-dystonia/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/deep-brain-stimulation-duration-and-changes-in-basal-ganglia-excitatory-inhibitory-balance-in-children-and-young-adults-with-dystonia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley